id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-D-2565-0011,FDA,FDA-2016-D-2565,Draft Guidance for Industry-510(k) Third Party Review Program,Other,Guidance,2018-09-14T04:00:00Z,2018,9,2018-09-14T04:00:00Z,2018-12-14T04:59:59Z,2024-11-07T01:38:07Z,,1,0,09000064836ef965
FDA-2016-D-2565-0010,FDA,FDA-2016-D-2565,"510(k) Third-Party Review Program; Draft Guidance for Industry, Food and Drug Administration Staff, and Third-Party Review Organizations;
Availability",Notice,Notice of Availability,2018-09-14T04:00:00Z,2018,9,2018-09-14T04:00:00Z,2018-12-14T04:59:59Z,2018-12-14T02:04:21Z,2018-19992,0,0,09000064836ee543